HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yuan Lu Selected Research

Kruppel-Like Transcription Factors (Kruppel-Like Factors)

10/2013Kruppel-like factor 15 is critical for vascular inflammation.
10/2012Kruppel-like factors and vascular inflammation: implications for atherosclerosis.
8/2010Kruppel-like factor 15 regulates smooth muscle response to vascular injury--brief report.
4/2010Klf15 deficiency is a molecular link between heart failure and aortic aneurysm formation.
8/2008The Kruppel-like factor KLF15 inhibits connective tissue growth factor (CTGF) expression in cardiac fibroblasts.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yuan Lu Research Topics

Disease

54Neoplasms (Cancer)
06/2022 - 02/2002
21Inflammation (Inflammations)
08/2021 - 10/2012
20Hypertension (High Blood Pressure)
01/2022 - 02/2008
15Hepatocellular Carcinoma (Hepatoma)
09/2022 - 12/2003
9Carcinogenesis
01/2022 - 09/2009
9Glioma (Gliomas)
01/2020 - 02/2002
8Infections
05/2022 - 02/2005
8Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 01/2005
7Ischemia
12/2021 - 01/2005
7Fibrosis (Cirrhosis)
01/2019 - 08/2008
7Sleepiness
01/2019 - 09/2015
7Endometriosis
06/2018 - 11/2008
7Leukemia
10/2017 - 12/2005
6COVID-19
01/2022 - 05/2020
6Heart Failure
01/2022 - 04/2010
6Liver Neoplasms (Liver Cancer)
12/2021 - 12/2010
6Reperfusion Injury
12/2021 - 06/2006
6Ovarian Neoplasms (Ovarian Cancer)
03/2020 - 01/2003
6Narcolepsy
01/2019 - 09/2015
6Myocardial Infarction
12/2018 - 01/2017
5Hypoxia (Hypoxemia)
09/2022 - 06/2003
5Lung Neoplasms (Lung Cancer)
06/2022 - 01/2016
5Asthma (Bronchial Asthma)
03/2022 - 11/2016
5Carcinoma (Carcinomatosis)
02/2022 - 03/2009
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2021 - 01/2016
5Hypersensitivity (Allergy)
01/2020 - 03/2013
5Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
01/2020 - 03/2013
5Melanoma (Melanoma, Malignant)
01/2020 - 01/2017
5Stroke (Strokes)
10/2019 - 04/2011
5Crohn Disease (Crohn's Disease)
01/2019 - 01/2013
5Prostatic Neoplasms (Prostate Cancer)
12/2015 - 03/2007
4Acute Kidney Injury (Acute Renal Failure)
09/2022 - 04/2014
4Thrombosis (Thrombus)
03/2022 - 04/2011
4Neoplasm Metastasis (Metastasis)
01/2021 - 03/2007
4Ulcerative Colitis
01/2021 - 12/2012
4Headache (Headaches)
01/2019 - 09/2015
4Nausea
01/2019 - 09/2015
4Wounds and Injuries (Trauma)
12/2016 - 03/2010
4Alzheimer Disease (Alzheimer's Disease)
01/2016 - 03/2012
4Atherosclerosis
10/2013 - 11/2004
3Adenocarcinoma of Lung
06/2022 - 01/2018
3Diabetes Mellitus
01/2022 - 05/2021
3ST Elevation Myocardial Infarction
01/2022 - 01/2021
3Myocardial Ischemia (Ischemic Heart Diseases)
01/2021 - 12/2018
3Diarrhea
04/2020 - 07/2016
3Ovarian Epithelial Carcinoma
03/2020 - 10/2009
3Necrosis
01/2019 - 04/2010
3Mitochondrial Diseases (Mitochondrial Disease)
01/2019 - 12/2017
3Hepatitis B
01/2016 - 08/2013

Drug/Important Bio-Agent (IBA)

25Proteins (Proteins, Gene)FDA Link
03/2021 - 09/2004
18Biomarkers (Surrogate Marker)IBA
01/2022 - 11/2008
15Pharmaceutical PreparationsIBA
05/2022 - 12/2014
15Messenger RNA (mRNA)IBA
02/2022 - 02/2002
10MicroRNAs (MicroRNA)IBA
01/2022 - 07/2009
9RNA (Ribonucleic Acid)IBA
12/2021 - 02/2002
9solriamfetolIBA
01/2019 - 09/2015
8Biological ProductsIBA
01/2022 - 09/2004
8LipidsIBA
01/2021 - 11/2004
8CholesterolIBA
01/2021 - 11/2004
7Antihypertensive Agents (Antihypertensives)IBA
01/2022 - 12/2017
7DNA (Deoxyribonucleic Acid)IBA
08/2011 - 01/2007
6EnzymesIBA
03/2022 - 01/2013
6C-Reactive ProteinIBA
01/2022 - 03/2015
6Monoclonal AntibodiesIBA
11/2018 - 06/2002
5CytokinesIBA
07/2021 - 09/2011
5Glucose (Dextrose)FDA LinkGeneric
05/2021 - 08/2013
5Long Noncoding RNAIBA
01/2021 - 11/2019
5Kruppel-Like Transcription Factors (Kruppel-Like Factors)IBA
10/2013 - 08/2008
4ErbB Receptors (EGF Receptor)IBA
08/2021 - 01/2016
4Blood Glucose (Blood Sugar)IBA
06/2021 - 04/2011
4Phosphotransferases (Kinase)IBA
03/2020 - 07/2010
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2018 - 09/2007
4salicylhydroxamic acid (SHAM)IBA
07/2018 - 11/2004
4Apolipoproteins E (ApoE)IBA
01/2016 - 12/2012
4bapineuzumabIBA
01/2016 - 03/2012
4Small Interfering RNA (siRNA)IBA
01/2016 - 12/2005
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2013 - 06/2003
3Interleukin-6 (Interleukin 6)IBA
09/2022 - 09/2011
3Fibrinogen (Factor I)FDA Link
09/2022 - 03/2015
3Circular RNAIBA
02/2022 - 02/2020
3Triglycerides (Triacylglycerol)IBA
10/2021 - 12/2017
3Peptides (Polypeptides)IBA
03/2021 - 04/2010
3LDL CholesterolIBA
01/2021 - 01/2016
3Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 05/2015
3Tumor Biomarkers (Tumor Markers)IBA
01/2021 - 09/2004
3AntagomirsIBA
01/2021 - 06/2020
3AntigensIBA
07/2020 - 12/2012
3Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2020 - 04/2010
3Interleukin-17 (Interleukin 17)IBA
12/2019 - 09/2011
3LigandsIBA
06/2019 - 12/2015
3Dopamine (Intropin)FDA LinkGeneric
01/2019 - 01/2019
3PlatinumIBA
11/2018 - 05/2018
3Amyloid (Amyloid Fibrils)IBA
01/2016 - 03/2012

Therapy/Procedure

29Therapeutics
01/2022 - 02/2003
11Chinese Traditional Medicine (Traditional Chinese Medicine)
03/2022 - 01/2014
10Moxibustion
01/2021 - 12/2012
8Drug Therapy (Chemotherapy)
03/2022 - 05/2005
6Percutaneous Coronary Intervention
09/2022 - 12/2018
3Ligation
07/2021 - 06/2020
3Electroacupuncture
01/2020 - 03/2013